PROJECT

Papers of the Month - JUL 00

  • To return to the home page, click here
    
    1. Harris PL, et al.  Incidence and risk factors of
    late rupture, and death after endovascular repair of
    infrarenal aortic aneurysms: The EUROSTAR experience. 
    J. Vasc. Surg.  2000; 32: 7349-49.
    
    Abstract, adapted from authors.  The Eurostar (European
    Collaborators on Stent/graft techniques for aneurysm
    repair) Registry was established in 1996 to collect
    data on the outcome of endovascular AAA treatment.  By
    March 2000, 2464 patients had been registered, with
    mean duration of followup was 12.19 months.  There were
    14 patients with confirmed rupture (5 survived
    emergency operation).  The cumulative risk of rupture
    was calculated to be 1% / year.  41 patients underwent
    late conversion to open repair (with a 75.6 mortality
    rate).  The cumulative risk of late conversion was
    approximately 2% / year.  Thus, the risk of late
    failure, according to analysis of observed hard
    endpoints, was 3 % / year.  The authors present
    extensive data on analysis of causes of late failure in
    hopes of improving results in the future.
    
    Comment by mdt:  A *very* impressive series.  We are
    now beginning to learn the natural history of
    endovascular grafts based on multi-institutional trials
    with large numbers of observed patients.
    
    2. Valentine, RJ, et al.  Watchful waiting in cases of
    small AAA -- appropriate for all patients?
    
    One-hundred and one male military veterans with AAA < 5
    cm were observed over time in the present study.  Sixty-
    nine were fully compliant with follow up examinations,
    and none died with rupture (mean follow up 34 months). 
    25 developed indication for repair over that time, and
    36 did not.  Among the non-compliant patients, three
    and possibly four died with rupture.  The authors
    conclude that noncompliant patients present a special
    problem, and they may be candidates for earlier
    intervention.
    
    Comment by mdt: I think the authors are right,
    especially considering the improving results with
    endovascular repair (as in the EUROSTAR trial).  The
    only problem I see is that it is not always easy to
    tell who will become non-compliant, until they become
    non-compliant.